Antithyroid drug regimens before and after 131I-therapy for hyperthyroidism:: evidence-based?

被引:0
作者
Mijnhout, G. S. [1 ]
Franken, A. A. M. [1 ]
机构
[1] Isala Clin, Dept Internal Med, Zwolle, Netherlands
关键词
antithyroid drugs; hyperthyroidism; radioiodine therapy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In view of the new national guideline on thyroid dysfunction, the evidence base for current practice as well as the new guideline is assessed with regard to the use of antithyroid drugs (ATDs) before and after radioiodine (I-131) therapy. Methods: In December 2006, we surveyed 16 hospitals by telephone about different aspects of their antithyroid drug regimen: all eight academic centres and eight nonacademic teaching hospitals. The literature was searched for an evidence-based answer to each question in the inquiry. Results: 13 of 16 hospitals (81%) use antithyroid drugs for pretreatment before I-131. ATDs are discontinued on average four days before I-131 or diagnostic scan. However, 27% stop only three days beforehand, which may diminish the effect of I-131. Propylthiouracil (PTU) is also withdrawn four days before I-131, although the literature shows that PTU diminishes the effect of I-131 even if it is stopped 15 days beforehand. Resumption of ATDs after I-131 to prevent thyrotoxicosis is common practice (81%). One hospital (6%) never restarts ATDs, two (13%) only by indication. Adjunctive treatment consists of combination therapy in 93%, is usually resumed within two days after I-131 therapy, and then continued for two to six months. Routine adjunctive treatment is not evidence-based and may be limited to a high-risk subset, especially elderly patients (> 70 years) and patients with cardiac comorbidity. Resumption of ATDs within five to seven days after I-131 may diminish the effect of I-131. Conclusion: Antithyroid drug regimens in the Netherlands are heterogeneous. The evidence base of current practice and the new guideline are discussed.
引用
收藏
页码:238 / 241
页数:4
相关论文
共 23 条
[1]   Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism [J].
Andrade, VA ;
Gross, JL ;
Maia, AL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4012-4016
[2]   The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: One-year follow-up of a prospective, randomized study [J].
Andrade, VA ;
Gross, JL ;
Maia, AL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3488-3493
[3]   ADJUNCTIVE TREATMENT WITH PROPYLTHIOURACIL OR IODINE FOLLOWING RADIOIODINE THERAPY FOR GRAVES-DISEASE [J].
BAZZI, MN ;
BAGCHI, N .
THYROID, 1993, 3 (04) :269-272
[4]   Propylthiouracil before 131I therapy of hyperthyroid diseases:: Effect on cure rate evaluated by a randomized clinical trial [J].
Bonnema, SJ ;
Bennedbæk, FN ;
Veje, A ;
Marving, J ;
Hegedüs, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4439-4444
[5]   Resumption of methimazole after 131I therapy of hyperthyroid diseases:: effect on thyroid function and volume evaluated by a randomized clinical trial [J].
Bonnema, SJ ;
Bennedbæk, FN ;
Gram, J ;
Veje, A ;
Marving, J ;
Hegedüs, L .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 149 (06) :485-492
[6]   Continuous methimazole therapy and its effect on the cure rate of hyperthyroidism using radioactive iodine:: An evaluation by a randomized trial [J].
Bonnema, Steen Joop ;
Bennedbaek, Finn Noe ;
Veje, Annegrete ;
Marving, Jens ;
Hegedus, Laszlo .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) :2946-2951
[7]   The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: A randomized clinical trial [J].
Braga, M ;
Walpert, N ;
Burch, HB ;
Solomon, BL ;
Cooper, DS .
THYROID, 2002, 12 (02) :135-139
[8]   DISCONTINUING ANTITHYROID DRUG-THERAPY BEFORE ABLATION WITH RADIOIODINE IN GRAVES-DISEASE [J].
BURCH, HB ;
SOLOMON, BL ;
WARTOFSKY, L ;
BURMAN, KD .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (08) :553-+
[9]   The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after 131I ablation for Graves disease [J].
Burch, HB ;
Solomon, BL ;
Cooper, DS ;
Ferguson, P ;
Walpert, N ;
Howard, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3016-3021
[10]   Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: Results of a prospective study [J].
Eschmann, S. M. ;
Thelen, M. H. ;
Dittmann, H. ;
Bares, R. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (05) :222-226